AMGEN BIOFARMACEUTICA, LDA secures contract for Adalimumab (Biosimilar) 40Mg/0 4Ml Sol Inj Pen 04 Ml Sc

Portugal, Feb. 2 -- Portugal based AMGEN BIOFARMACEUTICA, LDA has secured contract from Unidade Local De Saude De Almada-Seixal, Epe for Adalimumab (Biosimilar) 40Mg/0 4Ml Sol Inj Pen 04 Ml Sc. The value of the contract is worth 2160000 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....